Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.



) -- This quarter's earnings season has been difficult to navigate, Jim Cramer told

"Mad Money"

viewers Wednesday, but that doesn't mean there aren't winners out there.

Cramer said all the companies that have been bucking the trend of disappointments have one thing in common -- great execution.

Case in point,


(PPG) - Get Report



(DD) - Get Report

, a stock Cramer sadly owns for his charitable trust,

Action Alerts PLUS. Cramer said DuPont got hurt bad this quarter because it plays in the commodity chemical market. PPG, meanwhile, is a specialty chemical maker, developing innovative products for autos, aerospace and even sunglasses.

Then there's the case of

Buffalo Wild Wings



Chipotle Mexican Grill

(CMG) - Get Report


Panera Bread


. Same-store sales were disappointing at Wild Wings and Chipotle but not at Panera, which used new menu items to keep customers coming back for more, he added.

Even in the railroads, execution matters, said Cramer. That's why

Union Pacific

(UNP) - Get Report

is up 14% for the year while rival

Norfolk Southern's

(NSC) - Get Report

quarter came off the rails.

The trend is also evident in the industrials, noted Cramer, with


(HON) - Get Report

making strides with new products, while rival


(MMM) - Get Report

painted an uncertain picture for investors.

Cramer said the markets clearly aren't all bad, if investors know where to look.

Executive Decision

In the "Executive Decision" segment, Cramer sat down with Martin Franklin, executive chairman at



, a company that just delivered an earnings beat of 4 cents a share and a stock that's more than doubled since Cramer first recommended it in November 2009.

Franklin said Jarden is all about innovation, which is why his company makes a $1 million brand investment into itself each and every day. Whether it's developing new products, replacing older ones or promoting the products they have, Franklin said innovation will always be key to having a great company.

One such innovation Franklin debuted was a small and stylish smoke detector. He said it turns out smoke detectors don't have to be white, nor do they have to be so large or so boring. Other areas of innovation include the company's Rawlings sports equipment brand, which has invested heavily in a new football helmet design that debuted recently.

Jarden also has a commanding lead in the outdoor equipment market and is, in fact, the world's largest supplier of such equipment. Franklin said whether it's lanterns, snowboards, tents or sleeping bags, Jarden probably has a new, innovative product to show you.

Among Jarden's other accomplishments is its share price. The company recently performed a $500 million Dutch tender offer for its own shares. Franklin explained that during times when Jarden can't find a new brand to invest in, it is choosing to invest in itself by buying back shares to reward shareholders. Yet, despite the company's bold move, shares still trade at a paltry 11 times earnings.

Cramer continued his recommendation on Jarden.

Liking Facebook

Was the 20% jump higher in


(FB) - Get Report

justified? It was, according to Cramer, and the company may just be getting started after what remains the worst initial public offering in the history of the stock market.

Facebook not only had a terrific quarter but also a great conference call, one where it gave analysts and investors the answers they've been seeking for months. Facebook proved that its mobile strategy is in full swing now that its service is tightly integrated into the iPhone. A full 70% of users are now using Facebook on mobile devices and advertisers apparently love it. Facebook is now turning its attention to


(GOOG) - Get Report

Android platform.

Facebook also indicated that the problems with


(ZNGA) - Get Report

did not spill over into the overall gaming sector, which was the fear of many investors. Zynga now represents just 7% of Facebook sales, down from 12%.

Cramer said the strength in Facebook's quarter may be strong enough to overpower the share lockup expirations coming due soon, and he would be a buyer on weakness.

Lightning Round

In the Lightning Round, Cramer was bullish on


(CMI) - Get Report


American Capital Agency

(AGNC) - Get Report



(COST) - Get Report


Cramer was bearish on

Halcon Resources



Ford Motor

(F) - Get Report


In the Pipeline

In his second "Executive Decision" segment, Cramer sat down with Dr. Francois Nader, president and CEO of

NPS Pharmaceuticals


, an "orphan" drug maker that Cramer recommended on Sept 18. Shares of NPS spiked up 31% a month later on Oct. 12, at which time Cramer advised selling the stock. But he now says it may be worth investing in again as NPS has more than one new drug in its pipeline.

Nader explained that NPS looks for value in the drug market and orphan drugs provide that value because they have no competition, they cost far less to develop and there is still a true need for the products. Compare that to the $1.3 billion needed to bring a traditional blockbuster drug to market and it's easy to see why orphan drugs are far more attractive.

However, even with the orphan drug distinction, Nader noted NPS is still not going it alone. The company has major partners and licensing agreements for almost all of its drugs, helping to provide it with the cash it needs as well as a predictable profit picture in the future.

Cramer said that this drug maker is doing things right and he wants to continue to be a buyer.

Am I Diversified?

In the "Am I Diversified?" segment, Cramer spoke with callers and responded to tweets sent via Twitter to


to see if investors' portfolios have what it takes for today's markets.

The first portfolio included:

SPDR Gold Shares

(GLD) - Get Report



(AA) - Get Report



(CAT) - Get Report


Lululemon Athletica

(LULU) - Get Report


Chipotle Mexican Grill

(CMG) - Get Report


Cramer said that Lulu and Chipotle are both high-growth momentum stocks and this portfolio needs to replace Lulu with a drug stock like

Abbott Labs

(ABT) - Get Report

The second portfolio's top holdings included:


(COP) - Get Report



(T) - Get Report


Energy Transfer Partners



Eli Lilly

(LLY) - Get Report


Bank of America

(BAC) - Get Report


Cramer said that Conoco was too much like Energy Transfer and he would sell the latter in favor of

General Electric

(GE) - Get Report


The third portfolio had:


(BA) - Get Report


American Capital Agency

(AGNC) - Get Report



(ACN) - Get Report



(AAPL) - Get Report


Energy Transfer Partners


as its top five stocks.

Cramer said that this portfolio was terrific.

-- Written by Scott Rutt in Washington, D.C.

To email Scott about this article, click here:

Scott Rutt

Follow Scott on Twitter


or get updates on Facebook,


To watch replays of Cramer's video segments, visit the Mad Money page on CNBC


At the time of publication, Cramer's Action Alerts PLUS had a position in AAPL, DD, ETP and GE.

Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for, Inc., and CNBC, and a director and co-founder of All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of or its affiliates, or CNBC, NBC Universal or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or is related to the specific opinions expressed by him on "Mad Money."

None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.